World government

Sheridan tops Forbes Canada's Best Employers list

Retrieved on: 
Wednesday, January 25, 2023

OAKVILLE, ON, Jan. 25, 2023 /CNW/ - Forbes Magazine released its annual ranking of Canada's Best Employers today and Sheridan is first on the list.

Key Points: 
  • OAKVILLE, ON, Jan. 25, 2023 /CNW/ - Forbes Magazine released its annual ranking of Canada's Best Employers today and Sheridan is first on the list.
  • This is the fourth time Sheridan has been included in Forbes' ranking, moving from 8th spot in 2022.
  • The Forbes ranking includes 300 employers across 37 industries, ranging from large corporations to community-based financial institutions, post-secondary institutions and government agencies.
  • In 2022, Sheridan was also named to Forbes' list of Canada's Best Employers for Diversity — ranking 10th overall and the highest of any college in Canada.

WFH Gene Therapy Registry: now live!

Retrieved on: 
Wednesday, January 18, 2023

MONTREAL, Jan. 18, 2023 /PRNewswire/ - To ensure patient safety remains at the forefront of the work of the World Federation of Hemophilia (WFH), we have developed a registry to monitor the long-term safety and efficacy of gene therapy for people with hemophilia: the WFH Gene Therapy Registry (GTR).

Key Points: 
  • MONTREAL, Jan. 18, 2023 /PRNewswire/ - To ensure patient safety remains at the forefront of the work of the World Federation of Hemophilia (WFH), we have developed a registry to monitor the long-term safety and efficacy of gene therapy for people with hemophilia: the WFH Gene Therapy Registry (GTR).
  • The launch of the WFH GTR coincides with the approval of gene therapy for hemophilia by both the United States Food and Drug Administration (FDA)¹ and the European Medicines Agency (EMA)².
  • This worldwide endeavour aims to collect important data on all patients who receive gene therapy, whether through a clinical trial or through a post-marketed product.
  • The WFH GTR is now ready to enroll all PWH who have received gene therapy, through a clinical trial or through a marketed product.

WFH Gene Therapy Registry: now live!

Retrieved on: 
Wednesday, January 18, 2023

MONTREAL, Jan. 18, 2023 /PRNewswire/ -- To ensure patient safety remains at the forefront of the work of the World Federation of Hemophilia (WFH), we have developed a registry to monitor the long-term safety and efficacy of gene therapy for people with hemophilia: the WFH Gene Therapy Registry (GTR).

Key Points: 
  • MONTREAL, Jan. 18, 2023 /PRNewswire/ -- To ensure patient safety remains at the forefront of the work of the World Federation of Hemophilia (WFH), we have developed a registry to monitor the long-term safety and efficacy of gene therapy for people with hemophilia: the WFH Gene Therapy Registry (GTR).
  • The launch of the WFH GTR coincides with the approval of gene therapy for hemophilia by both the United States Food and Drug Administration (FDA)¹ and the European Medicines Agency (EMA)².
  • This worldwide endeavour aims to collect important data on all patients who receive gene therapy, whether through a clinical trial or through a post-marketed product.
  • The WFH GTR is now ready to enroll all PWH who have received gene therapy, through a clinical trial or through a marketed product.

Catalyte Acquires The Agency Shop to Expand Its Digital Marketing Apprentice Programs

Retrieved on: 
Monday, January 9, 2023

BALTIMORE, Jan. 9, 2023 /PRNewswire-PRWeb/ -- After a year of a successful partnership between the two companies, Catalyte has acquired The Agency Shop, a digital marketing consultancy. This move bolsters Catalyte's expanding digital marketing business unit supplying leading digital agencies and in-house media departments with the high-quality and diverse talent they need to succeed. The founders of The Agency Shop, Eric Yang, Lance Hollander and Kevin Woo, will join Catalyte's leadership team.

Key Points: 
  • BALTIMORE, Jan. 9, 2023 /PRNewswire-PRWeb/ -- After a year of a successful partnership between the two companies, Catalyte has acquired The Agency Shop, a digital marketing consultancy.
  • This move bolsters Catalyte's expanding digital marketing business unit supplying leading digital agencies and in-house media departments with the high-quality and diverse talent they need to succeed.
  • The founders of The Agency Shop, Eric Yang, Lance Hollander and Kevin Woo, will join Catalyte's leadership team.
  • "The Agency Shop came to us with the idea that we could apply our market-tested process for uncovering, unlocking and unleashing software development talent to the digital marketing industry," said Matthew Derella, CEO of Catalyte.

Coty Announces Appointment of Lubomira Rochet to Its Board of Directors

Retrieved on: 
Friday, January 6, 2023

Today, Coty (NYSE: COTY), one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care, announced the appointment of Lubomira Rochet to its Board of Directors, effective January 2, 2023.

Key Points: 
  • Today, Coty (NYSE: COTY), one of the world’s largest beauty companies with a portfolio of iconic brands across fragrance, color cosmetics, and skin and body care, announced the appointment of Lubomira Rochet to its Board of Directors, effective January 2, 2023.
  • Lubomira Rochet is a Partner at JAB Holding Company and brings over twenty years of experience in business and digital transformation.
  • Rochet’s work and impact was recognized in 2019, when she was named the “Marketer of the Year” by the World Federation of Advertisers.
  • Sue Y. Nabi, Coty’s CEO, said: “We are delighted to welcome Lubomira to our board of directors.

St. George's University School of Medicine Re-Approved By New York State Department of Education for Clinical Clerkships for Full Seven-Year Term

Retrieved on: 
Thursday, January 5, 2023

TRUE BLUE, Grenada, Jan. 5, 2023 /PRNewswire/ -- St. George's University's School of Medicine has received renewed approval from the New York State Department of Education (NYSED) for long-term clinical clerkships at affiliated hospitals and health systems in the state.

Key Points: 
  • TRUE BLUE, Grenada, Jan. 5, 2023 /PRNewswire/ -- St. George's University's School of Medicine has received renewed approval from the New York State Department of Education (NYSED) for long-term clinical clerkships at affiliated hospitals and health systems in the state.
  • The School of Medicine also demonstrated that it is financially stable, and that students have access to sufficient space, reference materials, and information technology platforms.
  • The re-approval by NYSED ensures continued access to New York State clinical sites for training following passage of the USMLE Step 1 exam.
  • New York, together with California, Florida, Georgia and New Jersey, are the states which require recognition for clinical training.

Bleeding Disorders Treatment Global Market Report 2022: Ukraine-Russia War Impact

Retrieved on: 
Tuesday, January 3, 2023

The bleeding disorders treatment market is expected to grow to $18.50 billion in 2026 at a CAGR of 7.9%.

Key Points: 
  • The bleeding disorders treatment market is expected to grow to $18.50 billion in 2026 at a CAGR of 7.9%.
  • The regions covered in the bleeding disorders treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
  • The bleeding disorders treatment market research report is one of a series of new reports that provides Bleeding disorders treatment market statistics, including bleeding disorders treatment industry global market size, regional shares, competitors with bleeding disorders treatment market share, detailed Bleeding disorders treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the bleeding disorders treatment industry.
  • This bleeding disorders treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Virtualware Releases 2022 Annual Report: Highlights Company's Achievements and Vision for the Future of Enterprise VR"

Retrieved on: 
Wednesday, December 28, 2022

BILBAO, Spain, Dec. 28, 2022 /PRNewswire/ -- Virtualware , one of Europe's leading virtual reality (VR) companies, is pleased to announce the release of its 2022 annual report .

Key Points: 
  • BILBAO, Spain, Dec. 28, 2022 /PRNewswire/ -- Virtualware , one of Europe's leading virtual reality (VR) companies, is pleased to announce the release of its 2022 annual report .
  • The document highlights the company's achievements during this year 2022, including the release of VIROO 2.0, the latest version of its flagship VR platform, and its recognition as the world's most innovative VR company.
  • During the past few months, Virtualware,
    Continued to thrive as one of the fastest-growing and most innovative virtual reality for industry companies in 2022.
  • Virtualware invites stakeholders to consult its 2022 annual report to learn more about the company's vision for the future of enterprise VR and the innovative solutions it is developing to shape that future.

Virtualware Releases 2022 Annual Report: Highlights Company's Achievements and Vision for the Future of Enterprise VR"

Retrieved on: 
Wednesday, December 28, 2022

BILBAO, Spain, Dec. 28, 2022 /PRNewswire/ -- Virtualware , one of Europe's leading virtual reality (VR) companies, is pleased to announce the release of its 2022 annual report .

Key Points: 
  • BILBAO, Spain, Dec. 28, 2022 /PRNewswire/ -- Virtualware , one of Europe's leading virtual reality (VR) companies, is pleased to announce the release of its 2022 annual report .
  • The document highlights the company's achievements during this year 2022, including the release of VIROO 2.0, the latest version of its flagship VR platform, and its recognition as the world's most innovative VR company.
  • During the past few months, Virtualware,
    Continued to thrive as one of the fastest-growing and most innovative virtual reality for industry companies in 2022.
  • Virtualware invites stakeholders to consult its 2022 annual report to learn more about the company's vision for the future of enterprise VR and the innovative solutions it is developing to shape that future.

Global Tech Industries Group, Inc. files Application for Listing on Blockchain-Powered Securities Exchange, Upstream

Retrieved on: 
Friday, December 9, 2022

Commenting on the application process, David Reichman, Chairman & CEO of GTII, stated, “We believe that our side of the application process is now complete, and we look forward to hearing from Upstream.

Key Points: 
  • Commenting on the application process, David Reichman, Chairman & CEO of GTII, stated, “We believe that our side of the application process is now complete, and we look forward to hearing from Upstream.
  • However, as an existing OTCQB company, GTII may be eligible for an expedited listing process.
  • About Global Tech Industries Group, Inc.: GTII is a publicly traded company incorporated in the state of Nevada, specializing in the support and pursuit of new and innovative technologies, through acquisition and/or joint venture.
  • About Upstream: a MERJ Exchange Market ( MERJ Exchange ), is a fully regulated global stock exchange for digital securities and NFTs.